-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million

Dow Jones·04/16/2026 20:15:00

Please log in to view news